Meditation-Based Stress Reduction in Rheumatoid Arthritis

Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis

The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).

Study Overview

Study Type

Interventional

Enrollment

80

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21207
        • University of Maryland School of Medicine - Kernan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Confirmed diagnosis of RA, with doctor's letter or doctors' bill with ICD code 714;
  • 18 years of age or older;
  • Able to read and write English;
  • Able to attend 15 course sessions and questionnaire sessions at Kernan Hospital in Baltimore;
  • Willing to practice skills for 45 minutes to 1 hour per day, 6 days a week;
  • Stable on rheumatoid medications for at least one month.

Exclusion criteria:

  • Major psychiatric illness (bipolar disorder, multiple personality disorder, etc.);
  • Active alcoholism or drug dependency;
  • Scheduled for major surgery during the study period;
  • Enrolled in randomized clinical trial for rheumatoid arthritis during the study period;
  • Planning to move out of the area in the next 12 months;
  • Unwilling to be enrolled in a control group;
  • Use of assistive device other than a cane;
  • Serious health condition(s) that the investigator determines would make it difficult to complete the 6 month study;
  • Diagnosis of fibromyalgia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brian Berman, MD, Director, Center for Integrative Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2003

Study Completion

March 1, 2005

Study Registration Dates

First Submitted

October 17, 2003

First Submitted That Met QC Criteria

October 20, 2003

First Posted (ESTIMATE)

October 21, 2003

Study Record Updates

Last Update Posted (ESTIMATE)

March 7, 2008

Last Update Submitted That Met QC Criteria

March 5, 2008

Last Verified

March 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on stress reduction program

3
Subscribe